"Don't wait to get the important care you need. At Ascension, we have changed the ways we provide care. In-person and virtual visits are available. When you need care, Ascension is committed to keeping you safe while you're receiving it. Our hospitals and clinics have implemented safety precautions to protect our patients and our care teams. From screening our associates to rigorous cleaning and disinfecting procedures, we are balancing care with caution. Call to discuss the right option for your care and to learn more about specific safety and visitor guidelines."

During the past decade, Austin Children's Chest Associates conducted 5 clinical trials. In the 10-year time frame, 5 clinical trials started and 5 clinical trials were completed, i.e. on average, 100% percent of trials that started reached the finish line to date. In the past 5 years, 0 clinical trials started and 4 clinical trials were completed. i.e. 0% of trials that started reached the finish line.

Out of the total clinical trials conducted in "Austin Children's Chest Associates" #1 sponsor was "Vertex Pharmaceuticals Incorporated" with 3 trials, followed by "Gilead Sciences" with 1 trials sponsored, "Merck Sharp & Dohme LLC" with 1 trials sponsored, "Parion Sciences" with 1 trials sponsored and "Savara Inc." with 1 trials sponsored. Other sponsors include -4 different institutions and companies that sponsored additional 6 trials in total.

In terms of collaborators to trials, out of the total clinical trials conducted in "Austin Children's Chest Associates" #1 collaborator was "Cystic Fibrosis Foundation" with 1 trials as a collaborator, "National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK)" with 1 trials as a collaborator and "Vertex Pharmaceuticals Incorporated" with 1 trials as a collaborator. Other collaborators include -3 different institutions and companies that were collaborators in the rest 3 trials.

According to Clinical.Site data, the most researched conditions in "Austin Children's Chest Associates" are "Cystic Fibrosis" (8 trials), "Exocrine Pancreatic Insufficiency" (1 trials), "Growth Failure" (1 trials) and "MRSA" (1 trials). Many other conditions were trialed in "Austin Children's Chest Associates" in a lesser frequency.

Most popular intervention types in "Austin Children's Chest Associates" are "Drug" (7 trials). Other intervention types were less common.

The name of intervention was led by "IVA" (3 trials), "Placebo" (2 trials), "TEZ/IVA" (2 trials), "AZLI" (1 trials) and "Denufosol Tetrasodium (INS37217) Inhalation Solution" (1 trials). Other intervention names were less common.

The vast majority of trials in "Austin Children's Chest Associates" are 8 trials for "All" genders.

Currently, there are NaN active trials in "Austin Children's Chest Associates". undefined are not yet recruiting, undefined are recruiting, 1 are Active, not recruiting, and undefined are Enrolling by invitation. In total, there were 7 completed trials in Austin Children's Chest Associates, undefined suspended trials, and undefined terminated clinical trials to date.

Out of the total trials that were conducted in Austin Children's Chest Associates, 1 "Phase 1" clinical trials were conducted, 2 "Phase 2" clinical trials and 5 "Phase 3" clinical trials were conducted as well. "Phase 4" trials included 0 trials, and there were also 0 trials that are defined as “Not Applicable".